Top Markets
Coin of the day
Eikon Therapeutics, Inc. Common Stock Eikon Therapeutics, Inc. Common Stock

Eikon Therapeutics, Inc. Common Stock

EIKN
Classifica tra le azioni #12325
Eikon Therapeutics, Inc. is a clinical biopharmaceutical company, established... Eikon Therapeutics, Inc. is a clinical biopharmaceutical company, established in 2019 and headquartered in Millbrae, California, operating within the United States. The company is dedicated to developing groundbreaking medicines to address significant unmet medical needs. It utilizes a proprietary platform capable of precisely characterizing protein interactions inside living cells. Eikon's drug pipeline includes EIK1001, a systemically delivered TLR 7/8 dual-agonist designed to activate both innate and adaptive anti-cancer immune responses; EIK1003 and EIK1004, which are selective PARP1 inhibitors for ovarian, breast, prostate, and pancreatic cancers. Notably, EIK1004 is brain-penetrant, offering a therapeutic approach for brain metastases and primary brain malignancies. Additionally, EIK1005 is a potent WRN helicase inhibitor and anti-tumor agent aimed at MSI-high tumors, alongside EIK1006.
Prezzo delle azioni
$11.03
Ultima sincronizzazione: 2026-08-28
Capitalizzazione di mercato
$597.15M
Variazione (1 giorno)
-4.25%
Variazione (1 anno)
-
Paese
US
Scambia Eikon Therapeutics, Inc. Common Stock (EIKN)

Categoria

Storico del prezzo dell'azione per Eikon Therapeutics, Inc. Common Stock (EIKN)
Prezzo di chiusura più alto: $10.87 il 2026-08-01

Prezzo di chiusura più basso: $14.75 il 2026-02-01
Storico del prezzo dell'azione di Eikon Therapeutics, Inc. Common Stock dal 2026 al 2026
Andamento annuale del prezzo dell'azione
Anno Performance
Non abbastanza dati per le date fornite.
Prezzo dell'azione per aziende simili o concorrenti
Azienda Prezzo dell'azione Variazione 1a% Il paese
$542.09 38.63%
US
$1.03K 44.13%
NL
$120.62 -13.35%
AU
$138.18 473.58%
US
$759.27 7.20%
CH